The landscape of liver disease management is experiencing a profound transformation as medical science embraces a metabolic-centered approach to hepatic pathology. This revolutionary shift from traditional Non-Alcoholic Steatohepatitis (NASH) concepts to metabolic dysfunction-associated steatohepatitis (MASH) represents a fundamental evolution in understanding how systemic metabolic disorders drive liver disease progression and treatment responses. Redefining Liver Disease… Read.